Predictably, the big presidential symposium at ASGCT reserved a slot for Jean Bennett, who led one of the three teams that have tested a gene transfer strategy for a rare genetic form of blindness, Leber’s Congenital Amaurosis (LCA). Unpredictably, however, Bennett trotted out one of her “treated” patients, Cory Haas, along with his two parents,… Continue reading ASGCT, continued: Eyes on Stage
Tag: ASGCT
ASGCT in Washington DC
Another year, another annual meeting of the American Society of Gene Therapy- now rechristened American Society of Gene AND CELL Therapy. The meeting ends today, and I am way behind in posts. There have been, to my knowledge, no startling new revelations about high impact trials or disastrous adverse events. The studies of Leber’s Congenital… Continue reading ASGCT in Washington DC
Soft Cells and C-Sections
The American Society of Gene Therapy is renaming itself: “American Society of Gene and Cell Therapy” (membership has yet to finalize the name change.” The European Society of Gene Therapy has already done so: “European Society of Gene and Cell Therapy.” Why is gene transfer going cellular? The publicly stated reasons are two fold. First… Continue reading Soft Cells and C-Sections